Schöb D S, Reichelt A C, Gross A J, Abt D, Miernik A, Gratzke C
Medizinische Fakultät, Klinik für Urologie, Universitätsklinikum Freiburg, Hugstetterstr. 55, 79106, Freiburg, Deutschland.
Abteilung für Urologie, Asklepios Klinik Barmbek, Rübenkamp 220, 22291, Hamburg, Deutschland.
Urologe A. 2020 Mar;59(3):347-358. doi: 10.1007/s00120-020-01149-1.
In recent years new surgical techniques to treat benign prostatic hyperplasia have been introduced into urological practice and evaluated in clinical studies. Complications of standard procedures, e.g. transurethral resection of the prostate (TURP), can be avoided while maintaining equivalent clinical outcomes. The main goal is preservation of erectile and ejaculatory function. Furthermore, outpatient treatment associated with a rapid patient recovery would be desirable. This article presents the course of the interventions, the mechanisms of action and current clinical evidence for novel mechanical approaches of recanalization, water-based ablation as well as prostate artery embolization. Initial study results partially indicate that in the future practically all patients can be offered an individualized surgical technique, which provides optimal symptomatic and functional improvements with a minimized risk of complications.
近年来，治疗良性前列腺增生的新手术技术已被引入泌尿外科实践并在临床研究中进行评估。在保持同等临床效果的同时，可以避免标准手术（如经尿道前列腺切除术（TURP））的并发症。主要目标是保留勃起和射精功能。此外，与患者快速康复相关的门诊治疗是可取的。本文介绍了再通的新型机械方法、水基消融以及前列腺动脉栓塞的干预过程、作用机制和当前临床证据。初步研究结果部分表明，未来几乎所有患者都可以接受个体化手术技术，该技术能以最小的并发症风险提供最佳的症状和功能改善。
